BEAT7-001 is a single group study (supplementation). Using a multi-modal brain imaging
portfolio, this study will assess whether brain energy metabolism (glucose and ketones),
structure or functional connectivity change in older people with frontal glucose
hypometabolism after 28 days on an oral dose of 1 g/kg/day of triheptanoin.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Université de Sherbrooke
Collaborators:
Fonds de la Recherche en Santé du Québec Ultragenyx Pharmaceutical Inc